Psychedelic therapy often promises transcendent mystical experiences. But research suggests context and expectation may matter more than the trip itself.
Articles on Psychedelic
Displaying all articles
The psychotropic allure of the ayahuasca plant for hundreds of thousands of non-Indigenous consciousness seekers is raising many concerns.
Researchers found a sharp rise in calls to US poison centers about magic mushrooms coincided with their decriminalization in several US cities and states.
Substantial economic growth in the psychedelic drugs market has drawn interest from corporations and start-ups. While this may accelerate research, it also sparks concerns about conflicts of interest.
One in seven Canadian veterans is living with PTSD. Developing a psychedelics research program for veterans should be a public health priority.
This latest research provides hope for people whose symptoms are harder to treat.
Receiving a cancer diagnosis and undergoing cancer treatment can be a traumatizing experience. Psychedelics like LSD, psilocybin and MDMA could help alleviate symptoms from cancer-related PTSD.
Alberta’s new policy on psychedelic-assisted therapy for mental illness may set a precedent that moves Canadians one step closer to accepting psychedelics as medicinal substances.
A transcript of an episode of The Conversation Weekly published on September 29, 2022.
Society has very different attitudes to near-death experiences and psychedelics.
Psychedelics can help reset the brain, shaking it out of old patterns. The current state of uncertainty could have similar impacts - a metaphorical psychedelic dose - for new insights.
Top contributors
-
Research Scientist, Queen's Health Sciences and Assistant Professor, Department of Psychiatry, Queen's University, Ontario
-
Enterprise Fellow (Senior Research Fellow/Senior Lecturer), Adelaide University
-
Director, Executive Leadership Academy, University of California, Berkeley
-
Emeritus Professor, National Centre for Youth Substance Use Research, The University of Queensland
-
Researcher of Epidemiology, University of Virginia
-
Killam Postdoctoral Research Fellow, Dalhousie University; Queen's University, Ontario
-
Professor, Department of Psychiatry, Queen's University, Ontario
-
Senior Lecturer in Psychology, Leeds Beckett University
-
Host, The Conversation Weekly Podcast, The Conversation
-
Professor of Emergency Medicine and Pediatrics, University of Virginia
-
Distinguished Professor of Neurology and Psychiatry, Director of Psychedelics Division at Neuroscape, University of California, San Francisco
-
Professor and Canada Research Chair in the History of Health & Social Justice, University of Saskatchewan
-
Associate Science Editor & Co-Host of The Conversation Weekly Podcast, The Conversation
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Postdoctoral Researcher in Child Psychiatry, Vrije Universiteit Amsterdam